Man Li
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
-
- Advanced Breast Cancer Therapies
- Brain Metastases and Treatment
Papers in
-
- Advanced Breast Cancer Therapies 6
- Lung Cancer Treatments and Mutations 3
- Brain Metastases and Treatment 3
- Co-authors
- Shanshan Zhao (1 shared paper)Yunkun Zhang (1 shared paper)Li Wan (1 shared paper)Yuke Tian (1 shared paper)Joonho Bae (1 shared paper)Zuowei Zhao (6 shared papers)Wei Cheng (1 shared paper)Taishu Wang (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Controlled Release (2 papers)Scientific Reports (2 papers)Journal of Applied Microbiology (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Man Li
67 papers receiving 631 citations
Man Li's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 145
- Pulmonary and Respiratory Medicine 126
- Cancer Research 55
- Genetics 32
- Radiology, Nuclear Medicine and Imaging 46
Countries citing papers authored by Man Li
This map shows the geographic impact of Man Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Li more than expected).
Fields of papers citing papers by Man Li
This network shows the impact of papers produced by Man Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Li. The network helps show where Man Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent progress of CDK4/6 inhibitors’ current practice in breast cancer Hit paper breakdown → | 2024 | 78 |
| 2 | 2016 | 63 | |
| 3 | 2014 | 33 | |
| 4 | 2017 | 32 | |
| 5 | 2024 | 26 | |
| 6 | 2018 | 26 | |
| 7 | 2015 | 25 | |
| 8 | Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2025 | 22 |
| 9 | 2018 | 21 | |
| 10 | 2025 | 21 | |
| 11 | 2024 | 20 | |
| 12 | 2024 | 16 | |
| 13 | 1995 | 13 | |
| 14 | 2024 | 13 | |
| 15 | 2023 | 12 | |
| 16 | 2024 | 11 | |
| 17 | 2024 | 11 | |
| 18 | 2025 | 11 | |
| 19 | 2024 | 10 | |
| 20 | 2021 | 9 |
About Man Li
Man Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Biomedical Engineering and Epidemiology, having authored 74 papers that have together received 640 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (6 papers), Insurance and Financial Risk Management (3 papers), Lung Cancer Treatments and Mutations (3 papers), Brain Metastases and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers), Calcium signaling and nucleotide metabolism (2 papers) and Heat Transfer Mechanisms (2 papers). The work is most often cited by research in Oncology (145 citations), Pulmonary and Respiratory Medicine (126 citations), Cancer Research (55 citations), Genetics (32 citations) and Radiology, Nuclear Medicine and Imaging (46 citations). Man Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shanshan Zhao, Yunkun Zhang, Li Wan, Yuke Tian, Joonho Bae, Zuowei Zhao, Wei Cheng, Taishu Wang, Yue Wu and Ling Mei. Their work appears in journals such as Journal of Clinical Oncology, Journal of Controlled Release, Scientific Reports, Journal of Applied Microbiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.